Viewing Study NCT05742802


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-26 @ 2:40 AM
Study NCT ID: NCT05742802
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-23
First Post: 2023-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module